Fmoc-Asp-OHCAS# 119062-05-4 |
- PF-4708671
Catalog No.:BCC5031
CAS No.:1255517-76-0
- BIX 02565
Catalog No.:BCC4303
CAS No.:1311367-27-7
- BI-D1870
Catalog No.:BCC5030
CAS No.:501437-28-1
- CMK
Catalog No.:BCC1489
CAS No.:821794-90-5
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 119062-05-4 | SDF | Download SDF |
PubChem ID | 7019016 | Appearance | Powder |
Formula | C19H17NO6 | M.Wt | 355.4 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in water or 1% acetic acid | ||
Chemical Name | (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanedioic acid | ||
SMILES | C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NC(CC(=O)O)C(=O)O | ||
Standard InChIKey | KSDTXRUIZMTBNV-INIZCTEOSA-N | ||
Standard InChI | InChI=1S/C19H17NO6/c21-17(22)9-16(18(23)24)20-19(25)26-10-15-13-7-3-1-5-11(13)12-6-2-4-8-14(12)15/h1-8,15-16H,9-10H2,(H,20,25)(H,21,22)(H,23,24)/t16-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Fmoc-Asp-OH Dilution Calculator
Fmoc-Asp-OH Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.8137 mL | 14.0687 mL | 28.1373 mL | 56.2746 mL | 70.3433 mL |
5 mM | 0.5627 mL | 2.8137 mL | 5.6275 mL | 11.2549 mL | 14.0687 mL |
10 mM | 0.2814 mL | 1.4069 mL | 2.8137 mL | 5.6275 mL | 7.0343 mL |
50 mM | 0.0563 mL | 0.2814 mL | 0.5627 mL | 1.1255 mL | 1.4069 mL |
100 mM | 0.0281 mL | 0.1407 mL | 0.2814 mL | 0.5627 mL | 0.7034 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Fmoc-Asp-OH
- Euchrenone B1
Catalog No.:BCN3575
CAS No.:119061-09-5
- MRT67307
Catalog No.:BCC1779
CAS No.:1190378-57-4
- EB 47
Catalog No.:BCC2452
CAS No.:1190332-25-2
- PSI-7976
Catalog No.:BCC5138
CAS No.:1190308-01-0
- PSI-7977
Catalog No.:BCC1871
CAS No.:1190307-88-0
- Sarcandrone B
Catalog No.:BCN6074
CAS No.:1190225-48-9
- Sarcandrone A
Catalog No.:BCN6073
CAS No.:1190225-47-8
- M2 ion channel blocker
Catalog No.:BCC1726
CAS No.:1190215-03-2
- 4-[2-[(3-Ethyl-4-methyl-2-oxo-3-pyrrolin-1-yl)carboxamido]ethyl]benzenesulfonamide
Catalog No.:BCC8672
CAS No.:119018-29-0
- Abiesinol F
Catalog No.:BCN6418
CAS No.:1190070-91-7
- 2,2'-Biquinoline
Catalog No.:BCC8489
CAS No.:119-91-5
- 3,4-Dihydrocoumarin
Catalog No.:BCN6793
CAS No.:119-84-6
- Fluorobexarotene
Catalog No.:BCC6110
CAS No.:1190848-23-7
- Phellolactone
Catalog No.:BCN3467
CAS No.:1190897-23-4
- Linolenic acid ethyl ester
Catalog No.:BCN8333
CAS No.:1191-41-9
- 1-Acetoxy-5-deacetylbaccatin I
Catalog No.:BCN6357
CAS No.:119120-27-3
- IOWH-032
Catalog No.:BCC3922
CAS No.:1191252-49-9
- Ganomycin I
Catalog No.:BCN3504
CAS No.:1191255-15-8
- B-Raf inhibitor 1 dihydrochloride
Catalog No.:BCC4183
CAS No.:1191385-19-9
- 3-Oxosapriparaquinone
Catalog No.:BCN3153
CAS No.:119139-56-9
- Glychionide A
Catalog No.:BCN3250
CAS No.:119152-50-0
- Coronarin A
Catalog No.:BCN6075
CAS No.:119188-33-9
- Coronarin D
Catalog No.:BCN6076
CAS No.:119188-37-3
- Coronarin B
Catalog No.:BCN6077
CAS No.:119188-38-4
The aspartimide problem in Fmoc-based SPPS. Part I.[Pubmed:12587881]
J Pept Sci. 2003 Jan;9(1):36-46.
A variety of Asp beta-carboxy protecting groups, Hmb backbone protection and a range of Fmoc cleavage protocols have been employed in syntheses of the model hexapeptide H-VKDGYI-OH to investigate the aspartimide problem in more detail. The extent of formation of aspartimide and aspartimide-related by-products was determined by RP-HPLC. This study included three new Fmoc-Asp-OH derivatives: the beta-(4-pyridyl-diphenylmethyl) and beta-(9-phenyl-fluoren-9-yl) esters and also the orthoester Fmoc-beta-(4-methyl-2,6,7-trioxabicyclo[2.2.2]-oct-1-yl)-alanine. 3-Methylpent-3-yl protection of the Asp side chain resulted in significant improvements with respect to aspartimide formation. Complete suppression was achieved using the combination OtBu side chain protection and Hmb backbone protection for the preceding Gly residue.